Definitions
from The American Heritage® Dictionary of the English Language, 5th Edition.
- noun A salicylate drug derived from sulfasalazine, C7H7NO3, used primarily to treat inflammatory bowel disease.
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun The drug
mesalazine .
Etymologies
from The American Heritage® Dictionary of the English Language, 4th Edition
Support
Help support Wordnik (and make this page ad-free) by adopting the word mesalamine.
Examples
-
Metabolite levels were significantly higher in people who reported taking at least one of four different phthalate-containing medications: mesalamine (a colitis treatment), didanosine (for HIV), omeprazole (an ulcer treatment), and theophylline (for asthma and lung disease).
More concerns about phthalates: Effects may be cumulative 2009
-
Metabolite levels were significantly higher in people who reported taking at least one of four different phthalate-containing medications: mesalamine (a colitis treatment), didanosine (for HIV), omeprazole (an ulcer treatment), and theophylline (for asthma and lung disease).
More concerns about phthalates: Effects may be cumulative 2009
-
This 12-week study will evaluate once-daily mesalamine to treat irritable bowel syndrome with diarrhea.
-
Does it mean there won't be more products based on mesalamine, but I don't see an AB rated product anytime soon for PENTASA.
-
So doing noninferiority trials, again I think we'll see other mesalamine-based products coming forward, but it is hard for me to see how they get AB rating, and it really has stymied people in PENTASA land today.
-
VISICOL® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) Tablets, APRISO ™ (mesalamine) extended-release capsules 0.375 g.,
-
Note that treatment guidelines generally recommend starting with first-line agents mesalamine and systemic corticosteroids, then the immunosuppressant azathioprine, and finally anti-TNF therapies once conventional therapies have failed.
Medicaid and Medicare MedPageToday.com - medical news plus CME for physi 2010
-
Researchers found that mesalamine use among patients with inflammatory bowel disease was associated ...
THE MEDICAL NEWS Editors 2010
-
The study included 508 adults with moderate to severe Crohn's disease who had not undergone previous immunosuppressive or biologic therapy and were corticosteroid-dependent, being considered for a second course of systemic corticosteroids within 12 months, or had not had a response to at least four weeks of adequate doses of mesalamine or budesonide (Entocort).
Medicaid and Medicare MedPageToday.com - medical news plus CME for physi 2010
-
Treatment guidelines still generally recommend a "step up" approach, starting with first-line agents mesalamine and systemic corticosteroids, then the immunosuppressant azathioprine, and finally anti-TNF therapies once conventional therapies have failed.
Medicaid and Medicare MedPageToday.com - medical news plus CME for physi 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.